Evidence map›Paper›PMID 41774157›Full record

ReviewHerz2026

Contemporary insights and evolving clinical pathways in transcatheter tricuspid valve replacement.

J G da Rocha E Silva, L Stolz, H Kempton, L T Weckbach, T J Stocker, P Doldi, J Novotny, M Näbauer, Jörg Hausleiter

Abstract readReview
PubMed Publisher
In one paragraph

Review in Herz, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

J G da Rocha E SilvaMedizinische Klinik und Poliklinik I, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, Munich, Germany.
L StolzMedizinische Klinik und Poliklinik I, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, Munich, Germany.
H KemptonMedizinische Klinik und Poliklinik I, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, Munich, Germany.
L T WeckbachMedizinische Klinik und Poliklinik I, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, Munich, Germany.
T J StockerMedizinische Klinik und Poliklinik I, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, Munich, Germany.
P DoldiMedizinische Klinik und Poliklinik I, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, Munich, Germany.
J NovotnyMedizinische Klinik und Poliklinik I, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, Munich, Germany.
M NäbauerMedizinische Klinik und Poliklinik I, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, Munich, Germany.
Jörg HausleiterMedizinische Klinik und Poliklinik I, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Marchioninistr. 15, 81377, Munich, Germany. Joerg.Hausleiter@med.uni-muenchen.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transcatheter tricuspid valve replacement (TTVR) has emerged as an important therapeutic option for patients with severe tricuspid regurgitation (TR), particularly those with high surgical risk and complex anatomy. This review summarizes the current state of orthotopic TTVR, including patient selection, procedural considerations, and post-procedural care. Recent data demonstrate that TTVR provides consistent results and effective TR elimination, promotes reverse right ventricular (RV) remodeling, and improves symptoms and quality of life. In patients with massive or torrential baseline TR, TTVR has also been associated with reduced heart failure hospitalizations. Key challenges include conduction disturbances, bleeding complications, risk of afterload mismatch, and the need for long-term anticoagulation. As multiple devices become available, careful multidisciplinary evaluation, incorporating valve anatomy, RV function, pulmonary pressures, imaging quality, and comorbid conditions, remains essential for optimal therapy selection.

Indexed as

Cardiac CatheterizationCritical PathwaysHeart Valve ProsthesisHeart Valve Prosthesis ImplantationTricuspid ValveTricuspid Valve InsufficiencyHumansTreatment OutcomeMultimodal imagingPatient outcomesPulmonary hypertensionRight heart catheterizationTricuspid regurgitation

Identifiers

PMID41774157

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.